AIM: A horizon scan of nanomedicinal product on the market or undergoing clinical investigation by analyzing the current nanomedicinal landscape. MATERIALS & METHODS: The horizon scan includes a search of literature, clinical trial registries and the internet. RESULTS: This horizon scan yielded 175 nanomedicinal products. Most products were intended for cancer treatment, followed by infectious diseases. Polymer conjugates, liposomes and protein nanoparticles were the most used structures for nanomedicinal products. CONCLUSIONS: This paper provides an overview of nanomedicinal products on the market or undergoing clinical investigation, their application areas and specific properties.
AIM: A horizon scan of nanomedicinal product on the market or undergoing clinical investigation by analyzing the current nanomedicinal landscape. MATERIALS & METHODS: The horizon scan includes a search of literature, clinical trial registries and the internet. RESULTS: This horizon scan yielded 175 nanomedicinal products. Most products were intended for cancer treatment, followed by infectious diseases. Polymer conjugates, liposomes and protein nanoparticles were the most used structures for nanomedicinal products. CONCLUSIONS: This paper provides an overview of nanomedicinal products on the market or undergoing clinical investigation, their application areas and specific properties.
Authors: Airama Albisa; Emma Piacentini; Victor Sebastian; Manuel Arruebo; Jesus Santamaria; Lidietta Giorno Journal: Pharm Res Date: 2017-03-24 Impact factor: 4.200
Authors: Solène Guenat; Phil Purnell; Zoe G Davies; Maximilian Nawrath; Lindsay C Stringer; Giridhara Rathnaiah Babu; Muniyandi Balasubramanian; Erica E F Ballantyne; Bhuvana Kolar Bylappa; Bei Chen; Peta De Jager; Andrea Del Prete; Alessandro Di Nuovo; Cyril O Ehi-Eromosele; Mehran Eskandari Torbaghan; Karl L Evans; Markus Fraundorfer; Wissem Haouas; Josephat U Izunobi; Juan Carlos Jauregui-Correa; Bilal Y Kaddouh; Sonia Lewycka; Ana C MacIntosh; Christine Mady; Carsten Maple; Worku N Mhiret; Rozhen Kamal Mohammed-Amin; Olukunle Charles Olawole; Temilola Oluseyi; Caroline Orfila; Alessandro Ossola; Marion Pfeifer; Tony Pridmore; Moti L Rijal; Christine C Rega-Brodsky; Ian D Robertson; Christopher D F Rogers; Charles Rougé; Maryam B Rumaney; Mmabaledi K Seeletso; Mohammed Z Shaqura; L M Suresh; Martin N Sweeting; Nick Taylor Buck; M U Ukwuru; Thomas Verbeek; Hinrich Voss; Zia Wadud; Xinjun Wang; Neil Winn; Martin Dallimer Journal: Nat Commun Date: 2022-06-21 Impact factor: 17.694
Authors: Hanan Abumanhal-Masarweh; Dana da Silva; Maria Poley; Assaf Zinger; Evgenya Goldman; Nitzan Krinsky; Ron Kleiner; Gal Shenbach; Josh E Schroeder; Jeny Shklover; Janna Shainsky-Roitman; Avi Schroeder Journal: J Control Release Date: 2019-06-22 Impact factor: 9.776
Authors: James L Weaver; Grainne A Tobin; Taylor Ingle; Simona Bancos; David Stevens; Rodney Rouse; Kristina E Howard; David Goodwin; Alan Knapton; Xiaohong Li; Katherine Shea; Sharron Stewart; Lin Xu; Peter L Goering; Qin Zhang; Paul C Howard; Jessie Collins; Saeed Khan; Kidon Sung; Katherine M Tyner Journal: Part Fibre Toxicol Date: 2017-07-17 Impact factor: 9.400
Authors: Christina Giannakou; Margriet Vdz Park; Wim H de Jong; Henk van Loveren; Rob J Vandebriel; Robert E Geertsma Journal: Int J Nanomedicine Date: 2016-06-22
Authors: Walter Brand; Cornelle W Noorlander; Christina Giannakou; Wim H De Jong; Myrna W Kooi; Margriet Vdz Park; Rob J Vandebriel; Irene Em Bosselaers; Joep Hg Scholl; Robert E Geertsma Journal: Int J Nanomedicine Date: 2017-08-22